Added to YB: 2025-07-09
Pitch date: 2025-07-04
PAX.ST [bullish]
Paxman AB (publ)
-32.6%
current return
Author Info
No bio for this author
Company Info
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
Market Cap
SEK 1.8B
Pitch Price
SEK 82.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.63
P/E
73.73
EV/Sales
5.98
Sector
Health Care Equipment and Supplies
Category
growth
Weird Shit Investing 2025 - Paxman AB
PAX.ST: UK family-led medtech w/ scalp cooling system for chemo patients to prevent hair loss. Recently acquired main competitor, creating near-monopoly in growing market. 30% YOY growth, just reached profitability (EV/EBIT 49x). Potential 2027 EV/EBIT 12x w/ recurring USD revenue. CIPN cooling product launching Q2 2026 addresses serious chemo side effects.
Read full article (2 min)